Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients

被引:4
|
作者
Pinto, Patricia [1 ]
Ghosh, Kanjaksha [1 ]
Shetty, Shrimati [1 ]
机构
[1] ICMR, Natl Inst Immunohaematol, Mumbai 400012, Maharashtra, India
关键词
FVIII inhibitors; F8; inversions; Haemophilia A; India; FACTOR-VIII INHIBITORS; GENE;
D O I
10.1016/j.bcmd.2014.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FVIII inhibitor development in haemophilia A (HA) patients, especially those with severe manifestations is a serious adverse effect in patients with haemophilia A, and the clinical management of these patients is very difficult as most don't respond to conventional treatment. Many genetic and non-genetic risk factors have been proposed however, these are diverse in different population groups, highlighting the importance of determining specific risk factors for each population. F8 mutations and especially inversions, which are the most common causative mutation in severe HA, have been significantly associated with inhibitor development earlier, however there is no conclusive data so far with regard to Indian haemophiliacs. This study provides novel evidence that intron 22 inversions in the F8 gene are indeed significantly associated with FVIII inhibitor development in Indian haemophiliacs. Further studies with other risk factors would enable better insights into the immune response towards FVIII in these patients, and possibly help to characterize patients at a higher risk for inhibitor development. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 163
页数:3
相关论文
共 50 条
  • [31] Factor VIII gene (F8) mutation and inhibitor development in non-severe hemophilia A
    De Groot-Eckhardt, C. L.
    Van Velzen, A. S.
    Peters, M.
    Peerlinck, K.
    Oldenburg, J.
    Santagostino, E.
    Astermark, J.
    Van Heerde, W. L.
    Hermans, C.
    Morfini, M.
    Castaman, G.
    Haya, S.
    McRae, S.
    Reitter-Pfoertner, S. E.
    Kamphuisen, P. W.
    Van der Bom, J. G.
    Fijnvandraat, K. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 33 - 33
  • [32] Analysis of F8 mRNA in haemophilia A patients with silent mutations or presumptive splice site mutations
    Zimmermann, M.
    Gehrig, A.
    Rost, S.
    Oldenburg, J.
    Mueller, C. R.
    HAMOSTASEOLOGIE, 2010, 30 (4A): : S156 - S156
  • [33] SVA RETROTRANSPOSON INSERTION IN EXON 14 OF F8 GENE CAUSES SEVERE HAEMOPHILIA A
    Pshenichnikova, O.
    Salomashkina, V.
    Perina, F.
    Surin, V.
    HAEMOPHILIA, 2023, 29 : 33 - 33
  • [34] Predicting inhibitor development in severe haemophilia A patients
    Ter Avest, P. .
    Fischer, K.
    Santagostino, E.
    Yuste, V. Jimenez
    Van den Berg, M.
    Van der Bom, J. .
    HAEMOPHILIA, 2008, 14 : 53 - 53
  • [35] SCREENING FOR INVERSIONS IN THE FACTOR-VIII (F8) GENE CAUSING SEVERE HEMOPHILIA-A
    MILLAR, DS
    KAKKAR, VV
    COOPER, DN
    BLOOD COAGULATION & FIBRINOLYSIS, 1994, 5 (02) : 239 - 242
  • [36] Risk factors associated with inhibitor development in Chinese patients with haemophilia B
    Zhou, J.
    Ding, Q.
    Chen, Z.
    Yang, H.
    Lin, L.
    Wang, H.
    Wang, X.
    Wu, R.
    HAEMOPHILIA, 2015, 21 (04) : E286 - E293
  • [37] F8 mRNA studies in haemophilia A patients with different splice site mutations
    Castaman, G.
    Giacomelli, S. H.
    Mancuso, M. E.
    Sanna, S.
    Santagostino, E.
    Rodeghiero, F.
    HAEMOPHILIA, 2010, 16 (05) : 786 - 790
  • [38] A recurrent F8 mutation in Irish haemophilia A patients:: evidence for a founder effect
    Winter, P. C.
    Egan, H.
    Mcnulty, O.
    Jones, F. G. C.
    O'Donnell, J.
    Jenkins, P. V.
    HAEMOPHILIA, 2008, 14 (02) : 394 - 395
  • [39] The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A
    Kim, Ju Young
    You, Chur Woo
    BLOOD RESEARCH, 2019, 54 (03) : 204 - 209
  • [40] Type of F8 gene mutation in patients with haemophilia A undergoing prosthetic surgery
    Tagariello, G.
    Sartori, R.
    Tassinari, C.
    Belvini, D.
    Salviato, R.
    Radossi, P.
    HAEMOPHILIA, 2010, 16 : 26 - 26